Unit5BIUDspdf 2024 11 15 11 12 27
Unit5BIUDspdf 2024 11 15 11 12 27
(13PH0704)
Unit 5 (Part B)
Intrauterine Device
(IUDs)
Presented by:
Ms. Suman R. Borsadiya
Assistant Professor
FOP, MU
IUD-Intra Uterine Devices
Introduction
❖ The intrauterine device (IUD) is a small T-shaped device that is used as a method of
birth control designed for insertion through the cervix and placed in the uterus to
prevent pregnancy.
❖ IUDs also have been referred to as ''intrauterine contraception" (IUC).
❖ An IUD is a type of long-acting reversible contraception. IUDs have been shown to be
over 99% effective in preventing pregnancy.
❖ Contraceptives are devices or methods for preventing pregnancy, either by
preventing the fertilization of the female egg by the male sperm or by preventing
implantation of the fertilized egg.
Introduction
Historical background
❖ The modem era of the IUD started in 1909 when Richard Richter in Germany used a ring from
silkworm gut as an intrauterine device. This device was, the first genuine IUD.
❖ Ernst Grafenberg described in 1929 a device consisting of a core of silkworm gut encircled by
an alloy of copper, nickel, and zinc that was highly effective in preventing pregnancy; results of
his experiments started a strong controversy on the problem of the induction of PIO
(pelvic inflammatory disease) and European practitioners rejected the idea.
❖ Fortunately, in Japan in 1934, Tenrey Ota presented the results of his studies on the use of
elastic metallic rings as IUDs. The idea was accepted and the IUDs rapidly started to be used.
❖ Second-generation copper-T IUDs were also introduced in the 1970s.
❖ These devices had higher surface areas of copper, and for the first time consistently achieved
effectiveness rates of greater than 99%
Introduction
Anatomy of the Uterus
The uterus is a pear shaped; thick walled, muscular organ suspended in the anterior wall of
pelvic cavity. Fallopian tubes enter its upper portion, one on each side and the lower portion
of the uterus projects into the vagina. The uterine cavity is normally triangular in shape and
flattened anterior- posteriorly.
Introduction
Anatomy of the Uterus
The wall of the uterus consists of three layers:
Endometrium: It represents the mucous membrane which forms the inner coat of the uterine
wall. It consists of an epithelial lining and connective tissue with two types of arteries
supplying blood to the endometrium
Myometrium: It is a thick muscular middle layer made up of bundles of smooth muscles
embedded in connective tissue.
Peritoneum: It covers the uterus and is anchored to both sides of the pelvic cavity by broad
ligament
Intrauterine Devices (IUD's)
Intrauterine Devices (IUD's)
Development of IUD's
❖ These devices cause more endometrial compression and myometrium distention, leading
to uterine cramps, bleeding and expulsion of IUDs.
❖ Researchers developed IUDs in past 30 years with the aim to add antifertility agents to
more tolerated, smaller devices, such as T-shaped device, to enhance effectiveness; or
antifibrinolytic agents, such as e-amino-caproic acid and tranexamic acid to larger IUDs to
minimize the bleeding and pain.
Intrauterine Devices (IUD's)
Development of IUD's
❖ Tatum developed a T-shaped device that would work better with the shape of the uterus,
which forms a T when contracted. This reduced side effects significantly.
❖ Zipper 1968 added contraceptive metals (Cu) and Doyle and Clewe developed Progestin
releasing IUD.
❖ This development initiated a new era of R and D for long term JU contraception,
leading to generation of recent IUDs-medicated IUDs.
❖ Copper bearing IUDs such as Cu-7 and Progesterone releasing IUDs such as Progestasert
(approved by FDA in 1976) thus evolved.
Intrauterine Devices (IUD's)
Types of IUDs
1. Non-medicated IUDs
2. Medicated IUDs
Classification of
IUD’s
❖ Dr Antonio Scommegna, demonstrated the uterine effects of progesterone in the late 1960s
❖ He developed a hormone releasing device. and showed that it is as effective in preventing
pregnancy as the copper-bearing IUD.
❖ A device is a ‘T-shaped, consisting of a permeable polymer membrane which releases
progesterone at a predictable, controlled rate of 65 mg per 24 h over the period of a year.
❖ The levonorgestrel releasing intrauterine system (LNG-IUS) is a T-shaped polyethylene device
with a steroid reservoir around the vertical stem.
Mechanism of action
Mechanism of action
❖ The IUD induces an intense local inflammatory response, especially by the copper containing
devices, which in turn leads to lysosomal activation and other inflammatory changes that are
spermicidal. Whenever fertilization occurs, the same inflammatory actions are directed against
the developing embryo.
❖ Inert devices, such as the Lippes-leop, are more effective with increased size and extent of
contact with the endometrium. Certain metals, especially copper, greatly enhance the
contraceptive action of inert devices, probably by inducing a more intense local intrauterine
inflammatory response
❖ The progesterone carrying devices induce atrophic endometrial changes. which make the
endometrium a hostile site for implantation if fertilization and successful tubal transport have
occurred.
Mechanism of action
❖ It is not possible to demonstrate a single mode of action of the levonorgestrel-releasing IUD.
Scanty cervical mucus and strong suppression of the endometrium is the main factors behind the
contraceptive action of the device
❖ Other. suggested mechanisms to prevent conception are inhibition of sperm motility and function
inside the uterus and in the fallopian tubes, preventing fertilization and endometrial growth.
Applications of IUD's
❖ Applications of IUD's
• It is used as a contraceptive to prevent pregnancy.
• It can be suitable for use in Hormone Replacement Therapy.
• It can be safely used in women with heavy bleeding to prevent/control the same.
• In the treatment of fibroids.
THANK YOU!
MARWADI UNIVERSITY
Morbi Road, Rajkot, Gujrat
India 360003.
www.marwadiuniversity.ac.in